Drugs / DZ1
last change Sep 2011 re-read 3 minutes ago

DZ1

Developed for
nasopharyngeal carcinoma
Investigated by
Xiangya Hospital of Central South University

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01449942 May 2009 → Apr 2011 nasopharyngeal carcinoma Xiangya Hospital of Central South University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DZ1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01449942 ↗